Europe's main drug regulator has lifted a 7-year-old warning about possible suicidal risks from Chantix, Pfizer's smoking-cessation pill.
The European Medicines Agency's ruling could boost sales of Champix, the drug's name in Europe, by reassuring doctors and their patients trying to quit smoking that the prescription medicine doesn't have dangerous psychiatric side effects.
EU lifts suicide warning on Pfizer's smoking-cessation pill
Aucun commentaire:
Enregistrer un commentaire